TFIIIC110 Polyclonal Antibody, 20ul Virus Packaging GO annotations related to this

GO annotations related to this gene include DNA-directed RNA polymerase activity and RNA polymerase I transcription factor binding

The antigen is being used as a target for immunotherapy treatment of human carcinomas

the reference genome represents the coding allele

Additional splice variants of PARK2 have been described but currently lack transcript support

NONO (non-POU domain containing

TFIIIC110 Polyclonal Antibody, 20ul Virus Packaging GO annotations related to thisRequired for RNA polymerase III mediated transcription. Component of TFIIIC that initiates transcription complex assembly on tRNA and is required for transcription of 5S rRNA and other stable nuclear and cytoplasmic RNAs. May play a direct role in stabilizing interactions of TFIIIC2 with TFIIIC1.